Macular degeneration trials in Hungary

In Hungary 12 Also abroad 218

12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Where
Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs
Age
50 years and over
People
272 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00
Phase 3Taking people
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Where
Budapest, Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs, Szeged, Szombathely
Age
50 years to 85 years
People
975 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00
Phase 2/3Taking people
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Where
Budapest VI, Pécs, Zalaegerszeg
Age
60 years and over
People
274 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00
Phase 3Taking people
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Where
Budapest VIII, Budapest XIII, Debrecen, Pécs
Age
50 years and over
People
561 worldwide
Run by
AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00
Phase 3Taking people
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Budapest, Debrecen, Pécs, Szeged
Age
50 years and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
Phase 3Taking people
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Where
Budapest, Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs, Szeged, Szombathely, Zalaegerszeg
Age
50 years and over
People
304 worldwide
Run by
Amgen
See details and how to joinNCT07614776 · EU 2025-523500-72-00
Phase 2/3Not yet taking people in Hungary
A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
Where
Budapest, Budapest VIII, Debrecen, Pécs, Szeged
Age
65 years and over
People
125 worldwide
Run by
Shenzhen Oculgen Biomedical Technology Co. Ltd.
See details and how to join2026-526648-11-00 · EU 2026-526648-11-00
Phase 2/3Taking people
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Where
Budapest, Budapest VI, Budapest VIII, Budapest X, Budapest XIII, Debrecen, Pécs, Szeged, Zalaegerszeg
Age
18 years and over
People
250 worldwide
Run by
Eyebiotech Limited
See details and how to join2025-524894-17-00 · EU 2025-524894-17-00
Phase 2Taking people
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Where
Budapest, Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs, Szeged
Age
55 years and over
People
324 worldwide
Run by
ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00
Phase 2Taking people
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Where
Budapest, Debrecen, Pécs
Age
60 years and over
People
240 worldwide
Run by
ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00
Phase 2/3Taking people
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Where
Budapest
Age
50 years and over
People
960 worldwide
Run by
EyeBiotech Ltd.
See details and how to joinNCT07496567
Phase 2Enrolling by invitation
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
Where
Budapest XIII, Debrecen, Pécs
Age
50 years and over
People
865 worldwide
Run by
AbbVie
See details and how to joinNCT03999801 · EU 2023-505750-17-00